International
-
Global taskforce set to demystify and overcome vaccine hesitancy amid COVID-19 pandemic 19 February 2021 International experts are joining forces to combat vaccine hesitancy by tackling its root cause – misinformation – and arming key influencers with the facts.
-
National consortium to study the threats of new SARS-CoV-2 variants 15 January 2021 A new national research project to study the effects of emerging mutations in SARS-CoV-2 is launched today [15 January]. The £2.5 million UK Research and Innovation (UKRI)-funded 'G2P-UK' National Virology Consortium will study how mutations in the virus affect key outcomes such as how transmissible it is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.
-
Bristol part of European initiative to study diabetic kidney disease 7 February 2017 Researchers from the University of Bristol are part of a major pan European €28.9 million initiative that aims to improve the prevention and management of diabetic kidney disease (DKD), which is the leading cause of kidney failure in the world.
-
Sound-shaping super-material invented 27 February 2017 A super-material that bends, shapes and focuses sound waves that pass through it has been invented by scientists. The creation pushes the boundaries of metamaterials – a new class of finely-engineered surfaces that perform nature-defying tasks.
-
New research shows U.S. Republican politicians increasingly spread news on social media from untrustworthy sources 22 September 2022 A study analysing millions of Tweets has revealed that Republican members of the US Congress are increasingly circulating news from dubious sources, compared to their European counterparts.
-
Anonymous cell phone data can quantify behavioral changes for flu-like illnesses, study finds 28 January 2021 Being prepared for a pandemic, like COVID-19, depends on the ability to predict the course of the pandemic and the human behaviour that drives spread in the event of an outbreak. Cell phone metadata that is routinely collected by telecommunications providers can reveal changes of behavior in people who are diagnosed with a flu-like illness, while also protecting their anonymity, a new study has found. The research, led by Emory University and devised by the University of Bristol, is based on data drawn from a 2009 outbreak of H1N1 influenza in Iceland and published in Proceedings of the National Academy of Sciences (PNAS).
-
Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment 23 November 2022 Scientists have discovered why some coronaviruses are more likely to cause severe disease, which has remained a mystery, until now. Researchers of the University of Bristol-led study, published in Science Advances today [23 November], say their findings could lead to the development of a pan-coronavirus treatment to defeat all coronaviruses—from the 2002 SARS-CoV outbreak to Omicron, the current variant of SARS-CoV-2, as well as dangerous variants that may emerge in future.
-
New study unravels Darwin’s ‘abominable mystery’ surrounding origin of flowering plants 28 January 2021 The origin of flowering plants famously puzzled Charles Darwin, who described their sudden appearance in the fossil record from relatively recent geological times as an “abominable mystery”. This mystery has further deepened with an inexplicable discrepancy between the relatively recent fossil record and a much older time of origin of flowering plants estimated using genome data.
-
No evidence that dehorning black rhinos negatively impacts the species’ reproduction or survival, study finds 21 September 2022 There are no statistically significant differences in key factors of population growth - breeding, birth, survival, life span and death - between dehorned or horned black rhinos new research, conducted by the University of Bristol Vet School, Namibian Ministry of Environment, Forestry and Tourism, and Save the Rhino Trust has found.
-
How vitamins, steroids and potential antivirals might affect SARS-CoV-2 28 January 2021 Evidence is emerging that vitamin D – and possibly vitamins K and A – might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they – and other antiviral drugs – might work. The research indicates that these dietary supplements and compounds could bind to the viral spike protein and so might reduce SARS-CoV-2 infectivity. In contrast, cholesterol may increase infectivity, which could explain why having high cholesterol is considered a risk factor for serious disease.
View the for public events and lectures run by the University.